Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib

PLoS One. 2021 Jun 17;16(6):e0253671. doi: 10.1371/journal.pone.0253671. eCollection 2021.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0222259.].

Publication types

  • Published Erratum